reproductive health

Evidence-Based Evolution: How FDA Scientists Shielded Mifepristone Regulation From Political Interference

By MedXY 01/17/2026

A comprehensive review of over 5,000 FDA documents confirms that the agency's regulation of mifepristone between 2011 and 2023 was driven by clinical safety data and internal scientific consensus, remaining remarkably resilient against external political pressures.

news OB/GYN & Women's Health Public Health

Preconception Trace Metal Profiles in Couples: A New Frontier in Optimizing IVF Embryological Outcomes

By MedXY 12/27/2025

A prospective study of 1071 couples identifies that plasma trace metal concentrations in both partners significantly influence IVF success, with elements like iron and molybdenum showing benefits while silver and thallium pose risks to embryo quality.

Clinical Updates Diabetes & Endocrinology news

Undiagnosed Hyperandrogenism in Type 1 Diabetes: Clinical Evidence, Mechanisms, and Screening Implications

By MedXY 12/27/2025

Recent evidence reveals that one in four premenopausal women with Type 1 diabetes (T1D) suffers from undiagnosed androgen excess disorders, primarily the classic PCOS phenotype, necessitating routine screening and a recalibration of reproductive healthcare in diabetic management.

news Public Health

Benchmarking the Ovarian Reserve: New Population-Based Data Reveal Wide Variability in Young Women

By MedXY 12/25/2025

A Norwegian population-based study of 492 women aged 18-22 reveals significant inter-individual variability in ovarian volume, antral follicle count, and AMH levels, providing a critical baseline for understanding reproductive health before the onset of age-related decline.

Hematology-Oncology news

Addressing the Silent Crisis: Menstrual Pain and Abnormal Bleeding as Drivers of Acute Care in Sickle Cell Disease

By MedXY 12/21/2025

A multicenter study reveals that menstrual pain and abnormal uterine bleeding are highly prevalent in women with sickle cell disease and are linked to increased hospitalizations. Low awareness of hormonal therapies highlights a critical gap in interdisciplinary care and reproductive health management.

Clinical Updates news OB/GYN & Women's Health Specialties

Enhanced Therapeutic Outcomes in Overweight/Obese Women with PCOS: Combining Metformin and Semaglutide

By MedXY 09/16/2025

Combination therapy with metformin and semaglutide improves weight loss, metabolic parameters, menstrual function, and natural pregnancy rates in overweight/obese women with PCOS compared to metformin alone.

news OB/GYN & Women's Health Specialties

Understanding Reddish-Brown Discharge After Orgasm: Causes and Care

By MedXY 08/07/2025

Explore the physiological and pathological reasons behind reddish-brown discharge after orgasm and learn practical steps for maintaining reproductive health.

Clinical Updates Neurology news Specialties

Population Attributable Fractions of Established, Social-Psychological and Reproductive Risk Factors for Stroke Among Women: Evidence from UK Biobank

By MedXY 08/07/2025

This study quantifies how established, social-psychological, and reproductive factors contribute to stroke risk in women, highlighting the need for integrated prevention strategies across age groups.

Family Medicine & Nutrition Internal Medicine news

Decoding Menarche: Its Impact on Long-Term Health

By MedXY 07/29/2025

The age at which a woman experiences her first period could signal potential long-term health risks, including cardiometabolic and reproductive issues. A recent study sheds light on these connections and highlights the need for tailored healthcare strategies.